オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - bisoprolol fumarate, quantity: 5 mg - tablet, film coated - excipient ingredients: maize starch; crospovidone; magnesium stearate; colloidal anhydrous silica; iron oxide yellow; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - donepezil hydrochloride monohydrate, quantity: 5.22 mg (equivalent: donepezil hydrochloride, qty 5 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin - treatment of mild, moderate and severe alzheimer's disease.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - donepezil hydrochloride monohydrate, quantity: 10.43 mg (equivalent: donepezil hydrochloride, qty 10 ) - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; lecithin - treatment of mild, moderate and severe alzheimer's disease.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - memantine hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: titanium dioxide; poloxamer; colloidal anhydrous silica; purified talc; povidone; sodium starch glycollate type b; hyprolose; magnesium stearate; hypromellose; sodium starch glycollate type a; glucose; maize starch; propylene glycol - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. nongonococcal urethritis. appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - montelukast sodium, quantity: 10.38 mg (equivalent: montelukast, qty 10 mg) - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; croscarmellose sodium; microcrystalline cellulose; hyprolose; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; carnauba wax - prophylaxis and treatment of chronic asthma in adults 15 years of age and older. ,symptomatic treatment of seasonal allergic rhinitis.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - codeine phosphate hemihydrate, quantity: 12.8 mg; ibuprofen, quantity: 200 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - for temporary relief of acute moderate pain and inflammation in patients over the age of 12 years

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tramadol hydrochloride, quantity: 37.5 mg; paracetamol, quantity: 325 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; stearic acid; hyprolose; croscarmellose sodium; titanium dioxide; iron oxide yellow; macrogol 8000; hypromellose; povidone; pregelatinised maize starch - tramadol/paracetamol is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - solifenacin succinate, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; maize starch; lactose monohydrate; hypromellose; titanium dioxide; purified talc; macrogol 6000; iron oxide red - solifenacin lupin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - solifenacin succinate, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; maize starch; hypromellose; titanium dioxide; purified talc; iron oxide yellow; macrogol 6000 - solifenacin lupin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.